Drug Shortage Report for ORCIPRENALINE
Report ID | 77931 |
Drug Identification Number | 02236783 |
Brand name | ORCIPRENALINE |
Common or Proper name | ORCIPRENALINE |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | ORCIPRENALINE SULFATE |
Strength(s) | 2MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL |
Packaging size | 250ml |
ATC code | R03CB |
ATC description | ADRENERGICS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-03-06 |
Estimated end date | 2019-04-05 |
Actual end date | 2019-04-01 |
Shortage status | Resolved |
Updated date | 2019-08-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-08-22 | French | Compare |
v4 | 2019-08-22 | English | Compare |
v3 | 2019-03-07 | English | Compare |
v2 | 2019-03-06 | French | Compare |
v1 | 2019-03-06 | English | Compare |
Showing 1 to 5 of 5